FOLH1 and adrenal cortex carcinoma: Lastly, we noted an ongoing trial based in China which aims to evaluate 68Ga-PSMA-617 uptake in local recurrent or metastatic ACC in comparison with 18F-FDG uptake in the same patients and assess the feasibility of 177Lu-EB-PSMA-617 treatment in patients with advanced ACC (NCT04801264).